secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocugen, Inc. (OCGN)
CIK:        0001372299
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001104659-26-054866
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocugen plans $115M convertible notes offering; preliminary cash $32.2M
----------------------------------------------------------------------

- Offering of $115M convertible senior notes due 2034, with initial purchaser option for additional $15M.
- Net proceeds used to repay ~$32.7M Avenue Capital loan plus accrued interest and fees; remainder for general corporate purposes.
- Preliminary cash, cash equivalents, and restricted cash of ~$32.2M as of March 31, 2026, unaudited.
- Notes are senior unsecured, convertible into cash, stock, or combination; interest rate and conversion rate TBD upon pricing.
- OCU400 Phase 3 enrollment complete, rolling BLA expected Q3 2026; OCU410ST trial fully dosed; OCU200 Phase 1 enrollment complete.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372299/000110465926054866/0001104659-26-054866-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372299/000110465926054866/tm2613474d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-054866

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer